BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26840621)

  • 1. The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges.
    Wang B; Cui Z; Zhong Z; Sun Y; Yang GY; Sun Q; Bian L
    Mol Carcinog; 2016 Dec; 55(12):2268-2277. PubMed ID: 26840621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer.
    Ikeda K; Saeki Y; Gonzalez-Agosti C; Ramesh V; Chiocca EA
    J Neurosurg; 1999 Jul; 91(1):85-92. PubMed ID: 10389885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis 2.
    Baser ME; R Evans DG; Gutmann DH
    Curr Opin Neurol; 2003 Feb; 16(1):27-33. PubMed ID: 12544854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases.
    Maxwell M; Shih SD; Galanopoulos T; Hedley-Whyte ET; Cosgrove GR
    J Neurosurg; 1998 Mar; 88(3):562-9. PubMed ID: 9488313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.
    Evans JJ; Jeun SS; Lee JH; Harwalkar JA; Shoshan Y; Cowell JK; Golubic M
    J Neurosurg; 2001 Jan; 94(1):111-7. PubMed ID: 11147878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion.
    Sun J; Tian X; Zhang J; Huang Y; Lin X; Chen L; Zhang S
    J Exp Clin Cancer Res; 2017 Aug; 36(1):100. PubMed ID: 28764788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts.
    Pykett MJ; Murphy M; Harnish PR; George DL
    Hum Mol Genet; 1994 Apr; 3(4):559-64. PubMed ID: 8069298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.
    Bachir S; Shah S; Shapiro S; Koehler A; Mahammedi A; Samy RN; Zuccarello M; Schorry E; Sengupta S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aberrant methylation of NF2, TIMP-3 and THBS1 genes and their diagnostic values in meningiomas].
    Gong J; Zhu SG; Wu CY; Li XG; Liu YG; Ren XH; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2889-92. PubMed ID: 23328233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
    Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
    Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.
    Kalamarides M; Stemmer-Rachamimov AO; Takahashi M; Han ZY; Chareyre F; Niwa-Kawakita M; Black PM; Carroll RS; Giovannini M
    Brain Pathol; 2008 Jan; 18(1):62-70. PubMed ID: 17924978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
    Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
    BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth.
    James MF; Lelke JM; Maccollin M; Plotkin SR; Stemmer-Rachamimov AO; Ramesh V; Gusella JF
    Neurobiol Dis; 2008 Feb; 29(2):278-92. PubMed ID: 17962031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation.
    Peyre M; Stemmer-Rachamimov A; Clermont-Taranchon E; Quentin S; El-Taraya N; Walczak C; Volk A; Niwa-Kawakita M; Karboul N; Giovannini M; Kalamarides M
    Oncogene; 2013 Sep; 32(36):4264-72. PubMed ID: 23045274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of PTPRJ/DEP-1 enhances NF2/Merlin-dependent meningioma development.
    Waldt N; Scharnetzki D; Kesseler C; Kirches E; Stroscher N; Böhmer FD; Mawrin C
    J Neurol Sci; 2020 Jan; 408():116553. PubMed ID: 31715329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of NF2 gene product merlin in arachnoid villi and meningiomas.
    Sakuda K; Kohda Y; Matsumoto T; Park C; Seto A; Tohma Y; Hasegawa M; Kida S; Nitta H; Yamashima T; Yamashita J
    Noshuyo Byori; 1996 Nov; 13(2):145-8. PubMed ID: 8958521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants.
    Wellenreuther R; Waha A; Vogel Y; Lenartz D; Schramm J; Wiestler OD; von Deimling A
    Lab Invest; 1997 Dec; 77(6):601-6. PubMed ID: 9426397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.
    Beauchamp RL; James MF; DeSouza PA; Wagh V; Zhao WN; Jordan JT; Stemmer-Rachamimov A; Plotkin SR; Gusella JF; Haggarty SJ; Ramesh V
    Oncotarget; 2015 Jul; 6(19):16981-97. PubMed ID: 26219339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.